
--- Page 1 ---
/es-0-3 Cavcinomx,in fi1trtng ouct N0s 85v6f3 UUID:5E997487-9A03-4723-81E6-FA08557D8FDF Redacted Site: brast. TCGA-D8-A27R-01A-PR NOS C50.9 ps 5/9/n page 1 / 2 original Examination: Histopathological examination Internal invoice No. Value of diagnostic procedure. Examination No. Patient: xxx PESEL: XXX Age: Gender: F  Material: Total organ resection -- right breast with axillary tissues Unit in charge:  Physician in charge: Material collected on: Material received on: Expected time of examination: up to 8 working days 579 Clinical diagnosis: Cancer of the right breast ? Examination performed on Macroscopic description:  Right breast szed 14.4 x 11.2 x 4.2 cm removed along with axillary tissues sized 8 x 5 x 2 cm and a skin flap of 12,2 x 8.8 cm. Weight 330 g. Tumour sized 3.2 x 2.3 x 2.6 cm found on the boundary of upper quadrants, located 1.6 cm from the upper boundary, 0.5 cm from the base and 1.2 cm from the skin.. Microscopic description: Carcinoma ductale invasivum - NHG3 (3 + 3 + 3 / 2 0 mitoses/10 HPF - visual area: 0.55mm).  Numerous foci of carcinoma ductale in situ Dcis found within the tumour (solid type with high nuclear atypia and comedo necrosis with calcinations, 20% of the tumour volume).  Invasio carcinomatosa vasovum massiva. Emboliae carcinomatosae mamillae. Glandular texture showing parenchyma of normal structure. In situ lesions removed by 0.1 cm from the base AXILLARY LYMPH NODES:  Metastases carcinomatosae in lymphonodis (No Xi/xI). Infitratio telae perinodalis.. Emboliae carcinomatosae vasorum. Test result: Incl. Examination  Metastases carcinomatosae in lymphonodis axillae. Cancer metastases in axillary lymph nodes. (No xi/xt) (NHG3, pT2, pN3a). Invasio carcinomatosa vasorum massiva. Massive vascular invasion.. Compliance validated by: Examination performed on'

--- Page 2 ---
page 2 / 2 Examination: Histopathological examination. Examination No.: peseL: XXx Gender: F Patient: xxx Examination performed on Results of immunohistochemical examination:. Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% neoplastic cel! nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Score=2+, FISH verification recommended. dr Compliance validated bye